Wassim Altarche Xifró, BS Pharm, PhD
Sales And Business Development Manager at Farmaprojects S.A.U. (Polpharma Group B.V)- Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Gold Feature
Click to upgrade to our gold package
for the full feature experience.
Location
Greater Barcelona Metropolitan Area, ES
Topline Score
Topline score feature will be out soon.
Bio
Generated by
Topline AI
You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now
Experience
-
Farmaprojects
-
Spain
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Sales And Business Development Manager
-
May 2022 - Present
-
-
-
LEMUS BUHILS, S.L.
-
Barcelona Area, Spain
-
Life-science Business Development & Licensing manager
-
Jul 2017 - Apr 2022
-
-
-
AB-BIOTICS
-
Spain
-
Biotechnology Research
-
1 - 100 Employee
-
Area Manager Middle East & Africa - International Business Development
-
Aug 2016 - Jun 2017
-
-
-
Centre for Genomic Regulation (CRG)
-
Spain
-
Biotechnology Research
-
200 - 300 Employee
-
Biomedical Research Scientist
-
Jun 2010 - Aug 2016
-
-
-
Universität Rostock
-
Germany
-
Research Services
-
700 & Above Employee
-
Biomedical Research Scientist
-
Jan 2010 - May 2010
-
-
-
Charité - Universitätsmedizin Berlin
-
Germany
-
Hospitals and Health Care
-
700 & Above Employee
-
Biomedical Research Scientist
-
Jan 2007 - May 2010
-
-
Biomedical research scientist
-
Jan 2006 - Dec 2006
-
-
-
Infociencia, Clinical Research Organization (CRO)
-
Barcelona Area, Spain
-
Clinical Trial Assistant (CTA)
-
Oct 2004 - Sep 2005
-
-
-
Fundació catalònia - Institut de salut Montserrat Montero
-
Cerdanyola del valles (Spain)
-
Pharmacist Assistant
-
May 2003 - Sep 2005
-
-
-
Hospital C.S. Parc Taulí
-
Hospital C.S. Parc Taulí, Sabadell (Spain)
-
Trainee Pharmacist - Hospital pharmacy
-
Mar 2004 - Sep 2004
-
-
Education
-
Humboldt University of Berlin
Doctor in Biology (Ph.D) -
Universitat de Barcelona
Licentiate degree
Community
You need to have a working account to view this content.
Click here to join now